A share price of Dexcom Inc [DXCM] is currently trading at $80.51, down -0.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The DXCM shares have gain 7.23% over the last week, with a monthly amount glided 5.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on August 21, 2025, when Argus initiated its Buy rating and assigned the stock a price target of $100. Previously, Truist started tracking the stock with Buy rating on June 16, 2025, and set its price target to $102. On May 30, 2025, Goldman initiated with a Buy rating and assigned a price target of $104 on the stock. Mizuho started tracking the stock assigning a Outperform rating and suggested a price target of $85 on April 10, 2025. Redburn Atlantic upgraded its rating to a Buy and raised its price target to $115 on February 03, 2025. Robert W. Baird upgraded its rating to Outperform for this stock on January 16, 2025, and upped its price target to $104. In a note dated July 26, 2024, Robert W. Baird downgraded a Neutral rating on this stock and revised its target price from $161 to $80.
Dexcom Inc experienced fluctuations in its stock price throughout the past year between $57.52 and $93.25. Currently, Wall Street analysts expect the stock to reach $81.36 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $80.51 at the most recent close of the market. An investor can expect a potential return of 1.06% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Trailing Twelve Months sales for Dexcom Inc [NASDAQ:DXCM] were 4.30B which represents 15.21% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.26 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 79.46 points at the first support level, and at 78.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.58, and for the 2nd resistance point, it is at 82.65.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Dexcom Inc [NASDAQ:DXCM] is 1.52. On the other hand, the Quick Ratio is 1.35, and the Cash Ratio is 0.35. Considering the valuation of this stock, the price to sales ratio is 7.34, the price to book ratio is 12.27 and price to earnings (TTM) ratio is 56.36.
Transactions by insiders
Recent insider trading involved Malady Kyle, Director, that happened on Sep 05 ’25 when 667.0 shares were purchased. Officer, SADIE STERN completed a deal on Sep 04 ’25 to buy 1466.0 shares. Meanwhile, EVP, Chief Financal Officer Sylvain Jereme M sold 4824.0 shares on Sep 02 ’25.
